US Patent 11945872 Anti-ACVR1 antibodies and uses thereof
Patent 11945872 was granted and assigned to Regeneron Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11945872 Anti-ACVR1 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.